Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)
Project Number5R01CA271033-04
Former Number5R01CA271033-02
Contact PI/Project LeaderIWELUNMOR, JULIET Other PIs
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
ABSTRACT
Cervical cancer is a major cause of morbidity and mortality in many sub-Saharan countries, including Nigeria.
Expanding human papillomavirus (HPV) vaccination for young girls/women, ages 9-26 years (primary
prevention) and HPV self-collection for cervical cancer screening for older women, ages 30-49 (secondary
prevention) are both critical to achieving WHO and Nigerian goals for reducing the cervical cancer burden. The
Nigerian government now recommends HPV vaccination and self-collection, yet uptake is poor. As such,
context-specific, targeted and culturally relevant implementation strategies are needed. We focus on HPV
vaccination among girls and self-collection among women because of the substantial burden of cervical
cancer. Mother-daughter relationships in Nigeria can be leveraged to increase HPV vaccination uptake among
young girls and HPV self-collection among mothers. Mothers (or similar female caregivers) profoundly
influence decisions and preferences about young girls’ vaccine uptake in the Nigerian cultural context. At the
same time, maternal choices about HPV self-collection can be reinforced in discussions with their daughters. In
the proposed study, Actions for Collaborative Community-Engaged Strategies for HPV (ACCESS-HPV), we will
use participatory crowdsourcing methods to drive HPV prevention among mother-daughter dyads.
Crowdsourcing open calls will allow us to identify locally relevant messages and dissemination techniques to
increase uptake of HPV prevention. Then, participatory learning communities will build capacity for community-
led implementation of selected strategies. Informed by social learning theory and the PEN-3 cultural model, our
multi-disciplinary research team proposes the following specific aims: (1) to develop a new combined
campaign to increase HPV vaccination for young girls (ages 9-26) and HPV self-collection for mothers (ages
30-49) using crowdsourcing open calls and participatory learning communities; (2) to determine the
effectiveness of a final combined campaign on uptake of HPV vaccination among young girls/women and HPV
self-collection among their mothers using a stepped-wedge randomized controlled trial; (3) to estimate the
impact and cost-effectiveness of the crowdsourced campaign. Our primary outcome will be vaccine uptake
(ascertained by clinic records of vaccine uptake) among young girls and HPV self-collection (ascertained by
laboratory receipt of specimens) among their mothers. The strong support of the Nigerian Institute for Medical
Research (NIMR) alongside national HPV programs creates a rich research infrastructure and increases the
likelihood of successful implementation. Our multi-disciplinary research team has experience organizing
implementation research focused on crowdsourcing and community participation in Nigeria. This study will
enhance our understanding of HPV prevention in resource-constrained settings. This grant application directly
responds to strategic priorities of the United States government, the National Institutes of Health, the National
Cancer Institute, and NOT-CA-20-025.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE
Although there is a substantial burden of cervical cancer among Nigerian women, there are significant gaps in
implementing both primary and secondary HPV prevention strategies. The study will engage young girls and
their mothers to increase uptake of essential HPV prevention services. The findings from this study will be
relevant to other resource-constrained settings that are expanding HPV vaccination and screening programs.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAddressAfricanAgeApplications GrantsAreaCancer BurdenCancer ControlCancerousCaregiversCervical Cancer ScreeningClinicCollectionCommunitiesCommunity Health AidesCommunity ParticipationCountryDaughterDevelopmentDissemination and ImplementationDoseEconomic ModelsElementsFemaleGoalsGovernmentGroup StructureHIVHPV screeningHPV vaccine acceptanceHealth Services AccessibilityHuman Papilloma Virus VaccinationHuman PapillomavirusHuman papillomavirus 6Immunization ProgramsIndividualInterdisciplinary StudyInterventionKnowledgeLaboratoriesLearningLesionMalignant NeoplasmsMalignant neoplasm of cervix uteriMedical ResearchMethodsModelingMorbidity - disease rateMothersNational Cancer InstituteNigeriaNigerianParticipantPopulationPreventionPrevention strategyPreventive measurePrimary PreventionProblem SolvingProctor frameworkQuality-Adjusted Life YearsRandomized, Controlled TrialsRecommendationRecordsResearchResearch InfrastructureResource-limited settingRiskSamplingSecondary PreventionServicesSpecimenState GovernmentStrategic PlanningTechniquesTimeUnited StatesUnited States National Institutes of HealthVaccinationWomanWorkYouthanti-cancer researchcancer preventioncancer vaccinationcommunity based participatory researchcommunity cliniccommunity engaged approachcost effectivenesscrowdsourcingdesigndirect applicationdissemination scienceeffectiveness evaluationexperienceexperimental studygirlshealth communicationimplementation evaluationimplementation outcomesimplementation processimplementation researchimplementation scienceimplementation strategyimprovedlearning communitylow and middle-income countriesmortalitymother-daughter relationshipolder womenpreferencepremalignantprevention serviceprimary outcomeprogramspublic health relevancerecruitrisk perceptionscale upscreeningscreening programsecondary outcomeself testingsocial cognitive theorytreatment as usualuptakevaccine acceptance
No Sub Projects information available for 5R01CA271033-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA271033-04
Patents
No Patents information available for 5R01CA271033-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA271033-04
Clinical Studies
No Clinical Studies information available for 5R01CA271033-04
News and More
Related News Releases
No news release information available for 5R01CA271033-04
History
No Historical information available for 5R01CA271033-04
Similar Projects
No Similar Projects information available for 5R01CA271033-04